222 related articles for article (PubMed ID: 11854434)
21. Kinin receptors: functional aspects.
Marceau F; Sabourin T; Houle S; Fortin JP; Petitclerc E; Molinaro G; Adam A
Int Immunopharmacol; 2002 Dec; 2(13-14):1729-39. PubMed ID: 12489786
[TBL] [Abstract][Full Text] [Related]
22. Kininase I-type carboxypeptidases enhance nitric oxide production in endothelial cells by generating bradykinin B1 receptor agonists.
Sangsree S; Brovkovych V; Minshall RD; Skidgel RA
Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H1959-68. PubMed ID: 12623793
[TBL] [Abstract][Full Text] [Related]
23. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta.
Fortin JP; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
J Pharmacol Exp Ther; 2005 Sep; 314(3):1169-76. PubMed ID: 15919764
[TBL] [Abstract][Full Text] [Related]
24. A novel nonpeptide antagonist of the kinin B1 receptor: effects at the rabbit receptor.
Morissette G; Fortin JP; Otis S; Bouthillier J; Marceau F
J Pharmacol Exp Ther; 2004 Dec; 311(3):1121-30. PubMed ID: 15277582
[TBL] [Abstract][Full Text] [Related]
25. Non-competitive pharmacological antagonism at the rabbit B(1) receptor.
Larrivée JF; Gera L; Houle S; Bouthillier J; Bachvarov DR; Stewart JM; Marceau F
Br J Pharmacol; 2000 Nov; 131(5):885-92. PubMed ID: 11053207
[TBL] [Abstract][Full Text] [Related]
26. Vascular kinin B(1) and B(2) receptor-mediated effects in the rat isolated perfused kidney - differential regulations.
Bagaté K; Develioglu L; Imbs JL; Michel B; Helwig JJ; Barthelmebs M
Br J Pharmacol; 1999 Dec; 128(8):1643-50. PubMed ID: 10588918
[TBL] [Abstract][Full Text] [Related]
27. P-Glycoprotein is localized in intermediate-density membrane microdomains distinct from classical lipid rafts and caveolar domains.
Radeva G; Perabo J; Sharom FJ
FEBS J; 2005 Oct; 272(19):4924-37. PubMed ID: 16176266
[TBL] [Abstract][Full Text] [Related]
28. Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled Galpha subunits Galphaq and Galphai in caveolae in DDT1 MF-2 smooth muscle cells.
de Weerd WF; Leeb-Lundberg LM
J Biol Chem; 1997 Jul; 272(28):17858-66. PubMed ID: 9211942
[TBL] [Abstract][Full Text] [Related]
29. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.
Drapeau G; deBlois D; Marceau F
J Pharmacol Exp Ther; 1991 Dec; 259(3):997-1003. PubMed ID: 1662280
[TBL] [Abstract][Full Text] [Related]
30. Bradykinin activates the Janus-activated kinase/signal transducers and activators of transcription (JAK/STAT) pathway in vascular endothelial cells: localization of JAK/STAT signalling proteins in plasmalemmal caveolae.
Ju H; Venema VJ; Liang H; Harris MB; Zou R; Venema RC
Biochem J; 2000 Oct; 351(Pt 1):257-64. PubMed ID: 10998369
[TBL] [Abstract][Full Text] [Related]
31. Stable expression of human kinin B1 receptor in 293 cells: pharmacological and functional characterization.
Bastian S; Loillier B; Paquet JL; Pruneau D
Br J Pharmacol; 1997 Sep; 122(2):393-9. PubMed ID: 9313952
[TBL] [Abstract][Full Text] [Related]
32. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
[TBL] [Abstract][Full Text] [Related]
33. N-terminal protein acylation confers localization to cholesterol, sphingolipid-enriched membranes but not to lipid rafts/caveolae.
McCabe JB; Berthiaume LG
Mol Biol Cell; 2001 Nov; 12(11):3601-17. PubMed ID: 11694592
[TBL] [Abstract][Full Text] [Related]
34. Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism.
Gera L; Fortin JP; Adam A; Stewart JM; Marceau F
J Pharmacol Exp Ther; 2006 Apr; 317(1):300-8. PubMed ID: 16368899
[TBL] [Abstract][Full Text] [Related]
35. Endotoxin sensitization to kinin B(1) receptor agonist in a non-human primate model: haemodynamic and pro-inflammatory effects.
deBlois D; Horlick RA
Br J Pharmacol; 2001 Jan; 132(1):327-35. PubMed ID: 11156593
[TBL] [Abstract][Full Text] [Related]
36. N-terminal extended conjugates of the agonists and antagonists of both bradykinin receptor subtypes: structure-activity relationship, cell imaging using ligands conjugated with fluorophores and prospect for functionally active cargoes.
Gera L; Roy C; Bawolak MT; Charest-Morin X; Marceau F
Peptides; 2012 Apr; 34(2):433-46. PubMed ID: 22349904
[TBL] [Abstract][Full Text] [Related]
37. Tissue kallikrein actions at the rabbit natural or recombinant kinin B2 receptors.
Houle S; Molinaro G; Adam A; Marceau F
Hypertension; 2003 Mar; 41(3):611-7. PubMed ID: 12623967
[TBL] [Abstract][Full Text] [Related]
38. High-affinity binding of peptide agonists to the human B1 bradykinin receptor depends on interaction between the peptide N-terminal L-lysine and the fourth extracellular domain of the receptor.
Fathy DB; Kyle DJ; Leeb-Lundberg LM
Mol Pharmacol; 2000 Jan; 57(1):171-9. PubMed ID: 10617692
[TBL] [Abstract][Full Text] [Related]
39. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
Butt SK; Dawson LG; Hall JM
Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687
[TBL] [Abstract][Full Text] [Related]
40. Cloning and pharmacological characterization of a rabbit bradykinin B1 receptor.
MacNeil T; Bierilo KK; Menke JG; Hess JF
Biochim Biophys Acta; 1995 Nov; 1264(2):223-8. PubMed ID: 7495867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
